149 related articles for article (PubMed ID: 16237777)
1. Clinicopathological significance of FHIT protein expression in gastric adenocarcinoma patients.
Zhao P; Liu W; Lu YL
World J Gastroenterol; 2005 Sep; 11(36):5735-8. PubMed ID: 16237777
[TBL] [Abstract][Full Text] [Related]
2. Low expression of FHIT and PTEN correlates with malignancy of gastric carcinomas: tissue-array findings.
Zheng H; Takahashi H; Murai Y; Cui Z; Nomoto K; Tsuneyama K; Takano Y
Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):432-40. PubMed ID: 18091387
[TBL] [Abstract][Full Text] [Related]
3. Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition.
Cao J; Chen XP; Li WL; Xia J; Du H; Tang WB; Wang H; Chen XW; Xiao HQ; Li YY
World J Gastroenterol; 2007 Feb; 13(7):1018-26. PubMed ID: 17373735
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of Fhit protein in Helicobacter pylori related chronic gastritis, gastric precancerous lesions and gastric carcinoma: correlation with conventional clinicopathologic parameters.
Skopelitou AS; Mitselou A; Katsanos KH; Alexopoulou V; Tsianos EV
Eur J Gastroenterol Hepatol; 2003 May; 15(5):515-23. PubMed ID: 12702909
[TBL] [Abstract][Full Text] [Related]
5. Inverse correlation of aberrant expression of fragile histidine triad (FHIT) protein with cyclin D1 protein and prognosis in Chinese patients with cholangiocarcinoma.
Zhao P; Lu Y; Zhong M; Liu L; Li B
Acta Oncol; 2008; 47(8):1557-63. PubMed ID: 18618300
[TBL] [Abstract][Full Text] [Related]
6. Fhit expression in gastric adenocarcinoma: correlation with disease stage and survival.
Capuzzi D; Santoro E; Hauck WW; Kovatich AJ; Rosato FE; Baffa R; Huebner K; McCue PA
Cancer; 2000 Jan; 88(1):24-34. PubMed ID: 10618602
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance of fragile histidine triad transcription protein expression in endometrial carcinomas.
Segawa T; Sasagawa T; Saijoh K; Inoue M
Clin Cancer Res; 2000 Jun; 6(6):2341-8. PubMed ID: 10873085
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of the fragile histidine triad gene in primary gastric adenocarcinomas.
Lee SH; Kim WH; Kim HK; Woo KM; Nam HS; Kim HS; Kim JG; Cho MH
Biochem Biophys Res Commun; 2001 Jun; 284(3):850-5. PubMed ID: 11396980
[TBL] [Abstract][Full Text] [Related]
9. FHIT protein expression and its relation to apoptosis, tumor histologic grade and prognosis in colorectal adenocarcinoma: an immunohistochemical and image analysis study.
Mady HH; Melhem MF
Clin Exp Metastasis; 2002; 19(4):351-8. PubMed ID: 12090476
[TBL] [Abstract][Full Text] [Related]
10. Loss of fragile histidine triad expression in colorectal carcinoma.
Zhao P; Lu Y; Hu Y; Zhong M; Li Z; Li X
Zhonghua Bing Li Xue Za Zhi; 2002 Apr; 31(2):124-7. PubMed ID: 12419158
[TBL] [Abstract][Full Text] [Related]
11. Fragile histidine triad expression in oral squamous cell carcinoma and precursor lesions.
Kujan O; Oliver R; Roz L; Sozzi G; Ribeiro N; Woodwards R; Thakker N; Sloan P
Clin Cancer Res; 2006 Nov; 12(22):6723-9. PubMed ID: 17121892
[TBL] [Abstract][Full Text] [Related]
12. Fhit, E-cadherin, p53, and activation-induced cytidine deaminase expression in endoscopically resected early stage esophageal squamous neoplasia.
Hayashi A; Yashima K; Takeda Y; Sasaki S; Kawaguchi K; Harada K; Murawaki Y; Ito H
J Gastroenterol Hepatol; 2012 Nov; 27(11):1752-8. PubMed ID: 22742976
[TBL] [Abstract][Full Text] [Related]
13. The significance of fragile histidine triad protein as a molecular prognostic marker of bladder urothelial carcinoma.
Zhang CT; Lu R; Lin YL; Liu RL; Zhang ZH; Yang K; Dang RF; Zhang HT; Shen YG; Kong PZ; Ren HL; Li XL; Quan W; Xu Y
J Int Med Res; 2012; 40(2):507-16. PubMed ID: 22613411
[TBL] [Abstract][Full Text] [Related]
14. Fhit protein expression in human gastric cancer and related precancerous lesions.
Caselli M; Marchisio M; Gaudio M; Saragoni L; Lanza G; Alvisi V; Bertagnolo V; Concu M; Capitani S; Caramelli E
Oncol Rep; 2001; 8(6):1233-7. PubMed ID: 11605039
[TBL] [Abstract][Full Text] [Related]
15. [Expressions of cyclinB1, FHIT and Ki-67 in 336 gastric carcinoma patients and their clinicopathologic significance].
Li YZ; Zhao P
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(33):2337-41. PubMed ID: 20095356
[TBL] [Abstract][Full Text] [Related]
16. [Fragile histidine triad protein expression and correlation with apoptosis in rectal carcinoma].
Cao J; Xia J; Wang H; DU H; Li WL
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Mar; 10(2):177-81. PubMed ID: 17380463
[TBL] [Abstract][Full Text] [Related]
17. Loss of FHIT protein expression correlates with disease progression and poor differentiation in gastric cancer.
Rocco A; Schandl L; Chen J; Wang H; Tulassay Z; McNamara D; Malfertheiner P; Ebert MP
J Cancer Res Clin Oncol; 2003 Feb; 129(2):84-8. PubMed ID: 12669232
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity and microsatellite instabilities of fragile histidine triad gene in gastric carcinoma.
Xiao YP; Wu DY; Xu L; Xin Y
World J Gastroenterol; 2006 Jun; 12(23):3766-9. PubMed ID: 16773697
[TBL] [Abstract][Full Text] [Related]
19. Loss of fragile histidine triad protein in human hepatocellular carcinoma.
Zhao P; Song X; Nin YY; Lu YL; Li XH
World J Gastroenterol; 2003 Jun; 9(6):1216-9. PubMed ID: 12800227
[TBL] [Abstract][Full Text] [Related]
20. [Loss of fragile histidine triad expression and metastasis in breast cancer].
Zhao P; Li XY; Chen LZ
Ai Zheng; 2002 Jun; 21(6):668-70. PubMed ID: 12452072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
